European Leukemia Trial Registry
Trial: APL 04-06

More Details
Title Combination Chemotherapy in Treating Patients With Newly Diagnosed APL
Scientific Title A Randomised Phase III Study to Compare Arsenic Trioxide (ATO) Combined to ATRA Versus Standard ATRA and Anthracycline-Based Chemotherapy (AIDA Regimen) for Newly Diagnosed, Non High-Risk Acute Promyelocytic Leukemia
Short Title APL 04-06
Trialgroup GIMEMA
Type of Trial multicentric, randomized
Disease Acute myeloid leukemia(AML) FAB M3 (APL)
Age <= 70 years
Status Closed
Start of Recruitment 01.11.2008
Leader Platzbecker, Prof. Dr. med., Uwe
Centre of Trial Universitätsklinikum Carl Gustav Carus, Dresden
Shortprotocol Shortprotocol
Remark www.sal-aml.org
created 25.06.2008 Roswitha Kotthoff
changed 10.07.2013 Sina Hehn
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org